Xiaochang Xue

2.1k total citations
90 papers, 1.7k citations indexed

About

Xiaochang Xue is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaochang Xue has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 28 papers in Immunology and 21 papers in Cancer Research. Recurrent topics in Xiaochang Xue's work include Immunotherapy and Immune Responses (15 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cancer-related molecular mechanisms research (9 papers). Xiaochang Xue is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cancer-related molecular mechanisms research (9 papers). Xiaochang Xue collaborates with scholars based in China, United States and Pakistan. Xiaochang Xue's co-authors include Yingqi Zhang, Qiang Hao, Cun Zhang, Weina Li, Suxia Yao, Yingzi Cong, Wangqian Zhang, Jintao Gu, Wei Zhang and Nan Mu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Xiaochang Xue

84 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaochang Xue China 22 954 503 350 276 140 90 1.7k
Eliana Abdelhay Brazil 26 1.1k 1.2× 452 0.9× 244 0.7× 474 1.7× 177 1.3× 125 2.0k
Kamiya Mehla United States 19 939 1.0× 623 1.2× 386 1.1× 377 1.4× 126 0.9× 27 1.6k
Meiling Yang China 21 765 0.8× 317 0.6× 341 1.0× 138 0.5× 140 1.0× 60 1.5k
Jian Zhao China 26 1.2k 1.2× 742 1.5× 351 1.0× 308 1.1× 161 1.1× 98 2.0k
Guey-Yueh Shi Taiwan 28 922 1.0× 438 0.9× 343 1.0× 182 0.7× 178 1.3× 75 2.0k
Soo‐Cheon Chae South Korea 26 1.1k 1.1× 283 0.6× 738 2.1× 371 1.3× 176 1.3× 106 2.4k
Kazimierz Węglarczyk Poland 21 1.4k 1.4× 684 1.4× 517 1.5× 385 1.4× 100 0.7× 62 2.1k
Jiajie Tu China 24 846 0.9× 464 0.9× 477 1.4× 293 1.1× 96 0.7× 61 1.8k
KyuBum Kwack South Korea 24 1.2k 1.2× 433 0.9× 412 1.2× 553 2.0× 113 0.8× 98 2.1k

Countries citing papers authored by Xiaochang Xue

Since Specialization
Citations

This map shows the geographic impact of Xiaochang Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochang Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochang Xue more than expected).

Fields of papers citing papers by Xiaochang Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochang Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochang Xue. The network helps show where Xiaochang Xue may publish in the future.

Co-authorship network of co-authors of Xiaochang Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochang Xue. A scholar is included among the top collaborators of Xiaochang Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochang Xue. Xiaochang Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lee, Hyowon, Waijiao Cai, Xiaochang Xue, et al.. (2024). Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers. npj Parkinson s Disease. 10(1). 152–152. 12 indexed citations
4.
Zhang, Fan, Na Fan, Ke Zhao, et al.. (2024). Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier. Journal of Translational Medicine. 22(1). 406–406. 33 indexed citations
5.
Liu, Xiao, Zhengcong Cao, Weizhong Wang, et al.. (2023). Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma. ACS Nano. 17(17). 16432–16447. 78 indexed citations
6.
Du, Ming‐Rui, Jintao Gu, Chenlin Liu, et al.. (2022). Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma. Journal of Experimental & Clinical Cancer Research. 41(1). 154–154. 21 indexed citations
7.
Chang, Fan, Jun Wang, Yan Wang, et al.. (2022). The essential differences in microbial and chemical components of musk of different qualities secreted by captive male forest musk deer ( Moschus berezovskii ). Microbial Biotechnology. 15(6). 1783–1794. 8 indexed citations
8.
Yang, Xiaolin, et al.. (2022). HPLC-DVD combined with chemometrics to analyze the correlation between the Q-marker content and color of Corni Fructus. Food & Function. 13(9). 5455–5465. 5 indexed citations
9.
Liu, Jianjun, Wenjing Hu, Yanan Zhang, et al.. (2019). miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Chu, Chu, Wangqian Zhang, Jialin Li, et al.. (2018). A Single Codon Optimization Enhances Recombinant Human TNF-α Vaccine Expression in Escherichia coli. BioMed Research International. 2018. 1–8. 6 indexed citations
11.
Zhang, Wangqian, Shuning Wang, Jintao Gu, et al.. (2018). Synergistic tumoricidal effect of combined hPD-L1 vaccine and HER2 gene vaccine. Biochemical and Biophysical Research Communications. 497(1). 394–400. 10 indexed citations
12.
Liu, Shuo, Nan Mu, Tonglie Huang, et al.. (2017). A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury. Journal of Controlled Release. 260. 32–45. 9 indexed citations
13.
Huang, Tonglie, Nan Mu, Jintao Gu, et al.. (2016). DDR2–CYR61–MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes. Journal of Bone and Mineral Research. 32(2). 407–418. 26 indexed citations
14.
Zhang, Cun, Yujin Xu, Qiang Hao, et al.. (2015). FOXP3 suppresses breast cancer metastasis through downregulation of CD44. International Journal of Cancer. 137(6). 1279–1290. 45 indexed citations
15.
Gao, Meili, Lei Chen, Yongfei Li, et al.. (2014). Synergistic Increase of Oxidative Stress and Tumor Markers in PAH-Exposed Workers. Asian Pacific Journal of Cancer Prevention. 15(17). 7105–7112. 13 indexed citations
16.
Gao, Meili, Yongfei Li, Xiaochang Xue, et al.. (2014). Impact of AhR, CYP1A1 and GSTM1 Genetic Polymorphisms on TP53 R273G Mutations in Individuals Exposed to Polycyclic Aromatic Hydrocarbons. Asian Pacific Journal of Cancer Prevention. 15(6). 2699–2705. 11 indexed citations
17.
Xue, Xiaochang, Anthony Cao, Xiaocang Cao, et al.. (2013). Downregulation of microRNA‐107 in intestinal CD11c+ myeloid cells in response to microbiota and proinflammatory cytokines increases IL‐23p19 expression. European Journal of Immunology. 44(3). 673–682. 55 indexed citations
18.
Li, Xiaowen Ma, Zhen Zhang, et al.. (2013). A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing. Drug Design Development and Therapy. 7. 1075–1075. 12 indexed citations
19.
Qin, Xin, Cun Zhang, Xiaochang Xue, et al.. (2012). Identification of a Novel Peptide Ligand of Human Transfrrin Receptor 1 for Targeted Tumor Delivery Drug. Protein and Peptide Letters. 20(1). 96–101. 8 indexed citations
20.
Li, Meng, Zhao Zhang, Xiaochang Xue, et al.. (2011). Phase II multicenter, randomized, double‐blind study of recombinant mutated human tumor necrosis factor‐α in combination with chemotherapies in cancer patients. Cancer Science. 103(2). 288–295. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliana Abdelhay Breakdown of academic impact, for papers by Kamiya Mehla Breakdown of academic impact, for papers by Meiling Yang Breakdown of academic impact, for papers by Jian Zhao Breakdown of academic impact, for papers by Guey-Yueh Shi Breakdown of academic impact, for papers by Soo‐Cheon Chae Breakdown of academic impact, for papers by Kazimierz Węglarczyk Breakdown of academic impact, for papers by Jiajie Tu Breakdown of academic impact, for papers by KyuBum Kwack
Rankless by CCL
2026